ERBB2 and neoplasm: High-affinity antibodies were shown to poorly penetrate into tumor tissue while an affinity of 10-7-10-8 M, as observed here for adecatumumab, was optimal for tumor penetration of anti-Her-2/neu single-chain antibodies [50].